Rosuvas F 20mg Tablet belongs to the therapeutic classification of Antihyperlipidemic Agents / Statin drugs. The primary composition for this medicine is Rosuvastatin 20 MG, Fenofibrate 160 MG.

Prolonged intake of statins is reported to cause severe musculoskeletal problems like myopathy and rhabdomyolysis. The most common adverse reactions associated with the use of Rosuvas F 20 Tablet 10's are muscle pain, muscle weakness, stomach upset, Nausea, headache, and asthenia (general unexplained weakness). Elderly patients are at greater risk of having muscle problems so it should be given with caution and only after consulting the doctor. Rosuvastatin present in Rosuvas F 20 Tablet 10's is a pregnancy category X medicine (high risk to both pregnant mother and fetus). Hence, it should not be used by pregnant or lactating mothers. Rosuvas F 20 Tablet 10's also passes into the breast milk but its safety and efficiency are unclear, so its intake should be avoided by the nursing mother. The use of a Rosuvas F 20 Tablet 10's should be avoided in all kidney patients and to be taken with caution in all liver disease patients. The use of alcohol with Rosuvas F 20 Tablet 10's increases liver damage, so its use should be avoided. Rosuvas F 20 Tablet 10's contains fenofibrate which is contraindicated in the gallstone patients, as there is an increased level of cholesterol in the bile leading to cholelithiasis.